✦ LIBER ✦

Peginterferon vs. interferon in the treatment of different HCV genotype infections in HIV patients

✍ Scribed by S. Zhao; D. Cheng; E. Liu; H. Yu; H. Yang; X. Xue; Y. Chu

Book ID: 106271969
Publisher: Springer
Year: 2008
Tongue: English
Weight: 257 KB
Volume: 27
Category: Article
ISSN: 0934-9723
DOI: 10.1007/s10096-008-0557-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HCV treatment with pegylated interferon

HCV treatment with pegylated interferon and ribavirin in patients with haemophilia and HIV/HCV co-infection

✍ J. T. DENHOLM; E. J. WRIGHT; A. STREET; J. J. SASADEUSZ 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

Impact of peginterferon alpha-2b and rib

Impact of peginterferon alpha-2b and ribavirin treatment on liver tissue in patients with HCV or HCV–HIV co-infection

✍ Rui Sarmento-Castro; Ana Horta; Olga Vasconcelos; Helena Coelho; Josefina Mendez 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 205 KB

Hepatitis C virus (HCV) treatment uptake

Hepatitis C virus (HCV) treatment uptake and changes in the prevalence of HCV genotypes in HIV/HCV-coinfected patients

✍ J. Medrano; S. Resino; E. Vispo; A. Madejón; P. Labarga; P. Tuma; L. Martín-Carb 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 469 KB

Pegylated α interferon 2B plus ribavirin

Pegylated α interferon 2B plus ribavirin in the treatment of HCV genotype 4 infection

✍ Tawhida Yassin Abdel Ghaffar; Suzan El Naghy; Hatem El Sebaie; Magda El Monaiery 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 122 KB

Efficacy of interferon in immunocompromi

Efficacy of interferon in immunocompromised HCV patients after liver transplantation or with HIV co-infection

✍ T. Reiberger; S. Rasoul-Rockenschaub; A. Rieger; P. Ferenci; A. Gangl; M. Peck-R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB

An early viral response to standard inte

An early viral response to standard interferon-alpha identifies resistance to combination therapy with peginterferon and ribavirin in patients infected by HCV genotype 1

✍ Hidenori Toyoda; Takashi Kumada; Seiki Kiriyama; Makoto Tanikawa; Yasuhiro Hisan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 1 views

## Abstract As combination therapy with peginterferon (PEG‐IFN) and ribavirin has a high morbidity, identifying individuals with hepatitis C virus (HCV) who will not respond to the treatment would be beneficial. The early responses of serum HCV RNA levels to standard interferon (IFN) and PEG‐IFN we